Planta Med 2007; 73(7): 689-695
DOI: 10.1055/s-2007-981529
Natural Product Chemistry
Original Paper
© Georg Thieme Verlag KG Stuttgart · New York

ent-Kaurane-Type Diterpenoids from a Cell Suspension Culture of the Liverwort Jungermannia subulata

Hiroshi Nozaki1 , Ken-ichiro Hayashi1 , Katsuaki Okuda1 , Fumito Kuyama1 , Kanji Ono2 , Akihiko Matsuo3
  • 1Department of Biochemistry, Okayama University of Science, Okayama City, Japan
  • 2Department of Biological Science, Faculty of Science, Kumamoto University, Kumamoto, Japan
  • 3Division of Environmental Biochemistry, Faculty of Social Information Science, Kure University, Kure City, Hiroshima, Japan
Further Information

Prof. Dr. Hiroshi Nozaki

Department of Biochemistry

Okayama University of Science

1-1 Ridai-cho

Okayama City 700-0005

Japan

Phone: +81-86-256-9460

Fax: +81-86-256-9559

Email: nozaki@dbc.ous.ac.jp

Publication History

Received: October 22, 2006 Revised: April 15, 2007

Accepted: April 17, 2007

Publication Date:
01 June 2007 (online)

Table of Contents #

Abstract

A cell suspension culture of the liverwort Jungermannia subulata was established from callus tissue induced by culturing spores. From the suspension culture, three new ent-kaurane-type diterpenoids were isolated together with three previously reported ent-kaurane-type diterpenoids. Five ent-kaurane-type diterpenoids were isolated from the intact J. subulata, two of which were new compounds. Their structures were determined by spectroscopic methods, chemical reaction, and X-ray crystallographic analysis.

#

Introduction

The liverwort (Hepaticae) is placed in a special group considered to represent an early stage in the evolution of terrestrial plants. The liverwort contains several oil bodies, a characteristic organelle of the liverwort, in each cell of the gametophyte. It has been shown that a liverwort usually accumulates sesquiterpenoids and diterpenoids as well as esters of fatty acids and aromatic compounds as the major lipophilic constituents in their oil bodies [1], [2]. In spite of the phytochemical and biochemical interest in the chemical constituents of the bryophytes, investigations have always encountered problems when collecting a sufficient quantity of the plants and also with botanical homogeneity. Recently, cell culture techniques have been applied to study the metabolites of the liverwort [3], [4]. In many cases, the production of characteristic secondary metabolites is significantly decreased or lost in higher plant cell cultures. This phenomenon could be due to the dedifferentiation of plant tissues, because a number of secondary metabolites are synthesized and accumulated at specific tissues such as root, bark, and leaf expressing certain biosynthetic genes. In contrast to higher plants, the liverwort has a simple morphology and accumulates secondary metabolites in the oil bodies. This oil body is observed in liverwort cell cultures as well as in intact plant cells, suggesting that a liverwort cell culture retains the ability to produce secondary metabolite [5], [6].

Several studies have reported that the chemical constituents differ among the same species of liverwort collected in different places [7], [8]. This suggests that different environmental conditions affect the metabolite profile in the liverwort. A liverwort cell culture is grown under constant culture conditions, suggesting that the metabolite profile of the cell culture is reproducible. Therefore, cell cultures of liverwort can solve the collection problem from natural sources and can provide a constant metabolite profile.

The genus Jungermannia (Jungermanniaceae, liverwort) produces various unique sesquiterpenoids and diterpenoids [9]. Jungermannia species produce bioactive ent-kaurane-type diterpenoids as one of the characteristic metabolites in this genus. ent-Kaurane-type diterpenoids have been reported to posses various interesting biological activities such as induction of apoptosis [10], [11], [12], potent cytotoxicity [13], anti-inflammatory activity [14], antiplatelet aggregation [15], inhibition of superoxide anion generation [16], and anti-HIV activity [17]. Therefore, Jungermannia species are attractive pharmacognosy sources of bioactive kaurane-type diterpenoids. These reports prompted us to produce bioactive kaurane-type diterpenoids by cell culture technology.

In this paper, we discuss the isolation and structural characterization of three new ent-kauranes together with three known ent-kaurane-type diterpenoids [7], [18] from a cell suspension culture, and two new ent-kaurane-type diterpenes in addition to three known ent-kauranes [7], [19] from the intact plant (Fig. [1]).

Zoom Image

Fig. 1 Chemical structures of kaurane-type diterpenoids (1 - 10) from the cell suspension culture and intact plant of the liverwort Jungermannia subulata.

#

Materials and Methods

#

General

All melting points were measured on a melting-point apparatus (Gallenkamp-Sanyo; Watford, UK) and are uncorrected. Optical rotations were measured with a SEPT-200 polarimeter (Horiba; Kyoto, Japan). UV spectra were recorded on a U-3210 spectrophotometer (Hitachi; Tokyo, Japan), and IR spectra on a model 1720 spectrometer (Perkin-Elmer Japan; Tokyo, Japan). 1H- and 13C-NMR spectra were recorded on an ARX 400 spectrometer (Bruker Japan; Tukuba, Japan), with chemical shifts shown in δ values from TMS as the internal reference, with peak multiplicities quoted in Hz. Mass spectra were measured on a JMS-700 spectrometer (Jeol; Tokyo, Japan). Column chromatography was carried out on silica gel 60 (70 - 230 and 230 - 400 mesh; Merck Japan; Tokyo, Japan).

#

Plant material

The liverwort Jungermannia subulata A. Evans (Jungermanniaceae) was collected in a forest on the Kanmuri mountain in Hatsukaichi city, Hiroshima prefecture, Japan in 1997 and identified by Prof. Naoki Nishimura (Okayama University of Science). A voucher specimen (OUS JS0233) has been deposited in the herbarium of Okayama University of Science.

#

Cell suspension culture

Mature spores were removed from sporangia that had been surface-sterilized with 1 % NaOCl solution for 10 min. Callus tissue was induced by culturing the spores on solid Murashige and Skoog (MS) medium [20] containing 2 % glucose and 0.8 % agar. This callus was suspended in a liquid MSG medium [MS medium containing 4 % glucose, 0.1 % CaCO3 and no phytohormones, pH 5.8] to establish a cell suspension culture. The suspension culture was routinely subcultured at 10 - 14 day intervals by pouring approximately 2 mL of cells into 100 mL fresh medium in a 300-mL conical flask. The flasks were placed on a gyratory shaker [120 rpm, 25 °C] under a continuous fluorescent light (3000 lux). Photographs of the cells were taken with an Olympus BX50 microscope.

#

Extraction and isolation

The cells were collected by filtering the suspension culture (9.6 L) during the growth phase. The whole cells (370 g) were dried in the shade for several days, and then cells were extracted twice with MeOH (1.5 L × 2) for a week at room temperature. The solvent was removed under reduced pressure. The resultant residue was suspended in water (1.5 L) and partitioned with n-hexane and EtOAc, respectively (1.5 L × 2).

The n-hexane extract (1.18 g) was first subjected to silica gel column chromatography (CC) [70 - 230 mesh, 6 × 100 cm, 1550 g], eluting with a gradient mixture of CHCl3-EtOAc [(100 - 80 : 20 - 60 : 40 - 50 : 50, V/V) - EtOAc, each 2 L] to give six fractions. Fraction 2 (2200 - 2700 mL, 195 mg) was subjected to silica gel CC [230 - 400 mesh, 1.5 × 25 cm, 38 g, n-hexane-EtOAc (9 : 1, 250 mL)] to give four fractions. Fraction 2 - 2 (100 - 150 mL, 95.1 mg) and fraction 2 - 3 (150 - 200 mL, 60.3 mg) were purified by silica gel CC [230 - 400 mesh, 1.5 × 25 cm, 38 g, n-hexane-EtOAc (9 : 1, 250 mL) for fraction 2 - 2; n-hexane-acetone (8 : 2, 250 mL) for fraction 2 - 3] to give phytol (73.6 mg) and compound 2 (46.7 mg), respectively. Fraction 3 (2700 - 3200 mL, 125 mg) was subjected to silica gel CC [230 - 400 mesh, 1.5 × 25 cm, 38 g, benzene-acetone (96 : 4, 250 mL)] to give four fractions. Fraction 3 - 2 (80 - 150 mL, 70.8 mg) was further purified by silica gel CC [230 - 400 mesh, 1.5 × 25 cm, 38 g, n-hexane-EtOAc (8 : 2, 250 mL)] to give compounds 1 (30.4 mg), 3 (1.2 mg), 4 (8.3 mg), and pheophorbide A methyl ester (4.3 mg), respectively.

The EtOAc extract (0.53 g) was subjected to silica gel CC [230 - 400 mesh, 3 × 60 cm, 230 g] using a gradual increase of addition of acetone to CHCl3 [(100 - 80 : 20 - 60 : 40 - 50 : 50, V/V)-acetone each 600 mL] to give seven fractions. Compounds 5 (1.5 mg) and 6 (2.6 mg) were isolated from fraction 4 (3200 - 3500 mL, 23.3 mg) and fraction 5 (3500 - 3700 mL, 12.8 mg), respectively, by repeated silica gel CC [230 - 400 mesh, 1 × 25 cm, 11 g] with benzene-acetone (1 : 1, 70 mL).

Air-dried J. subulata (100 g) was extracted with MeOH (1.5 L × 2) for a month. The MeOH extract was concentrated under vacuum and suspended in water. This aqueous suspension was extracted successively with n-hexane and EtOAc. The n-hexane extract (1.23 g) was divided into ten fractions by silica gel CC [70 - 230 mesh, 3 × 60 cm, 230 g] using an n-hexane-EtOAc gradient system [(100 - 80 : 20 - 60 : 40 - 50 : 50, V/V) - EtOAc, each 500 mL]. Fraction 2 (450 - 750 mL, 147.5 mg) was purified by silica gel CC [230 - 400 mesh, 1.5 × 25 cm, 38 g, n-hexane-EtOAc (9 : 1, 250 mL]] to give compound 7 (33.6 mg) and a triterpenoid, friedelin (19.5 mg). Silica gel CC [230 - 400 mesh, 1 × 30 cm, 13 g, benzene-EtOAc (15 : 1, 70 mL)] purification of fraction 3 (750 - 800 mL, 12.0 mg) resulted in the isolation of compound 9 (5.0 mg). From fraction 7 (1400 - 1500 mL, 40.0 mg), compound 3 (11.0 mg), together with β-sitosterol (4.4 mg), were purified by repeated silica gel CC [230 - 400 mesh, 1 × 25 cm, 11 g, n-hexane-EtOAc (9 : 1, 120 mL)]. Fractions 9 (1900 - 2000 mL, 39.5 mg) and 10 (2000 - 2200 mL, 27.3 mg) were separated by silica gel CC [230 - 400 mesh, 1.5 × 25 cm, 38 g, n-hexane-acetone (10 : 1, 120 mL) for fraction 9; n-hexane-EtOAc (9 : 1, 120 mL) for fraction 10] to yield compounds 8 (8.7 mg) and 10 (0.7 mg), respectively. The EtOAc extract (0.55 g) was subjected to silica gel CC [70 - 230 mesh, 2.5 × 30 cm, 81 g] with n-hexane-EtOAc [(100 - 80 : 20 - 60 : 40 - 50 : 50, V/V) - EtOAc, each 150 mL,] solvent gradient to give eleven fractions. Purification of fraction 3 (200 - 300 mL, 10.2 mg) and fraction 4 (300 - 350 mL, 6.2 mg) by silica gel CC [230 - 400 mesh, 1 × 25 cm, 11 g, n-hexane-EtOAc (85 : 15, 70 mL)] gave compounds 8 (1.3 mg) and 10 (0.7 mg), respectively.

15β-Hydroxy-ent-kaur-16-en-3-one (4): Crystalline needles; m. p. 129 - 132 °C; [α]D 25: -70.9 (c 0.2, CHCl3); IR (CHCl3): νmax = 3600, 1730 cm-1; 1H- and 13C-NMR spectroscopic data: see Table [1]; EI-MS: m/z (%) = 302 [M] + (100), 287 (50), 284 (30); HR-EI-MS: m/z = 302.2248 for C20H30O2 (Δmmu 0.2).

13α-Hydroxy-ent-kaur-16-ene-3,15-dione (5): Colorless crystals; m. p. 171 - 178 °C; [α]D 25: -132.3 (c 0.1, CHCl3); IR (CHCl3):  νmax = 3440, 1735 cm-1; 1H- and 13C-NMR spectroscopic data: see Table [1]; EI-MS: m/z (%) = 318 [M] + (100), 301 (40), 267 (50), 261 (70); HR-EI-MS: m/z = 318.2197 for C20H30O3 (Δmmu 0.2).

13α,15a-Dihydroxy-ent-kaur-16-en-3-one (6): Colorless crystals; m. p. 165 - 171 °C; [α]D 25: 27.5 (c 0.1, CHCl3); IR (CHCl3): νmax = 3620, 1700 cm-1; 1H- and 13C-NMR spectroscopic data: see Table [1]; EI-MS: m/z (%) = 318 [M]+ (100), 300 (90), 285 (30), 137 (75); HR-EI-MS: m/z = 318.2195 for C20H30O3 (Δ mmu 0.0).

7β-Hydroxykaur-16-en-15-one (9): Crystalline needles; m. p. 125 - 128 °C; [α]D 25: -75.0 (c 0.1, CHCl3); IR (CHCl3):  νmax = 3625, 1740 cm-1; UV (CHCl3): λmax (log ε) = 235 nm (3.79); 1H-NMR (CDCl3): δ = 0.83 (3H, s, H-19), 0.90 (3H, s, H-18), 1.11 (3H, s, H-20), 2.31 (1H, d, J = 10.0, H-14), 3.09 (1H, brs, H-13), 3.91 (1H, brs, H-7), 5.23 (1H, s, H-17), 5.97 (1H, s, H-17); 13C-NMR (CDCl3): δ = 39.6 (t, C-1), 18.4 (t, C-2), 41.8 (t, C-3), 33.3 (s, C-4), 53.2 (d, C-5), 26.0 (t, C-6), 72.9 (d, C-7), 53.2 (s, C-8), 45.2 (d, C-9), 40.1 (s, C-10), 18.1 (t, C-11), 32.7 (t, C-12), 38.1 (d, C-13), 32.6 (t, C-14), 214.5 (s, C-15), 149.4 (s, C-16), 115.7 (t, C-17), 34.6 (q, C-18), 21.8 (q, C-19), 17.6 (q, C-20); HR-EI-MS: m/z 302.2240 [M]+ for C20H30O2 (Δ mmu 0.6).

11α-Acetoxykaur-16-ene-3,15-dione (10): Colorless crystals; m. p. 221 - 224 °C; [α]D 25: -152.0 (c 0.1, CHCl3); IR (CHCl3): νmax = 1700 cm-1; UV (CHCl3): λmax (log ε) = 238 (3.59); 1H-NMR (CDCl3): δ = 1.04 (3H, s, H-19), 1.11 (3H, s, H-18), 1.17 (3H, s, H-20), 2.09 (3H, s, H-22), 2.48 (2H, dd, J = 7.4, 9.5 Hz, H-2), 5.42 (1H, d, J = 2.0, H-17), 6.09 (1H, d, J = 2.0, H-17); 13C-NMR (CDCl3): δ = 38.5 (t, C-1), 33.8 (t, C-2), 217.0 (s, C-3), 47.1 (s, C-4), 53.6 (d, C-5), 19.7 (t, C-6), 32.0 (t, C-7), 54.6 (s, C-8), 49.9 (d, C-9), 38.3 (s, C-10), 20.6 (t, C-11), 35.3 (t, C-12), 84.2 (s, C-13), 40.1 (t, C-14), 206.5 (s, C-15), 147.7 (s, C-16), 116.2 (t, C-17), 27.0 (q, C-18), 20.9 (q, C-19), 17.4 (q, C-20), 22.0 (q,CH3CO), 169.8 (s, CH3CO); HR-EI-MS: m/z = 358.2124 [M]+ for C22H30O4 (Δmmu 0.2).

#

Oxidation of 3α-hydroxy-ent-16(S)-kauran-15-one (1)

To a solution of 1 (3.1 mg) in Me2CO (3 mL) was added one drop of Jones reagent (CrO3, aq. H2SO4). After the mixture had been kept at room temperature for 3 h, it was diluted with H2O and the product extracted with Et2O. The Et2O extract was washed, dried and evaporated to give a ketone (2.3 mg) of which spectra and physico-chemical values were identicalto those of 2.

#

Oxidation of 4

Compound 4 (2.4 mg) in Me2CO (3 mL) was treated with an excess of Jones reagent at room temperature for 1 h. The product after extraction with Et2O was evaporated to give 3 (1.3 mg).

#

Catalytic hydrogenation of 3

Compound 3 (1.1 mg) in EtOAc (3 mL) was hydrogenated in the presence of 10 % Pd-C for 21 h. Work-up as usual gave a dihydro-derivative (0.6 mg), whose spectral and physico-chemical values were identical to those of 2.

#

Oxidation and catalytic hydrogenation of 6

To a solution of compound 6 (1.8 mg) in Me2CO (2 mL) was added one drop of Jones reagent. After 3 h, the mixture was diluted with H2O and the product was extracted with Et2O. The concentrated extract, without purification, was dissolved in EtOAc and hydrogenated in the presence of 10 % Pd/C for 24 h at 1 atm. Work-up of the reaction mixture gave 5 (0.7 mg).

#

X-ray crystallographic analyses of 3, 4, and 9

Crystal data of 3: C20H28O2, MW 300.44, monoclinic, space group P21, a = 6.6018(6) Å, b = 10.597(1), c = 12.1167(9), β  = 92.873(8)°, V = 846.6(1) Å3, D X = 1.178 g/cm3, Z = 2.

Crystal data of 4: C20H30O2, MW 302.46, monoclinic, space group C2, a = 18.59(1) Å, b = 7.431(1), c = 15.967(3), β = 130.55(2)°, V = 1676.1(8) Å3, D X = 1.198 g/cm3, Z = 4.

Crystal data of 9: C20H30O2, MW 302.46, orthorhombic, space group P212121, a = 10.865(2) Å, b = 24.868(3), c = 6.381(1), V = 1724.0(8) Å3, D X = 1.165 g/cm3, Z = 4.

The reflections of 4 were obtained on a Rigaku RAXIS-IV imaging plate area detector with graphite monochromated Mo-Kα radiation. The reflections of 3 and 9 were measured on a Rigaku AFC-7R diffractometer [graphite-monochromated Cu-Kα radiation (λ  = 1.54178 Å) for 3, graphite-monochromated Mo-Kα radiation (λ  = 0.71070 Å) for 9]. A total of 1468 reflections were obtained for 3 (1696 for 4, 1782 for 9), of which 1340 (1313 for 4, 1380 for 9) were unique (R int = 0.092 for 3, R int = 0.074 for 4, R int = 0.774 for 9). These crystal structures were solved by direct methods using the program teXsan, a crystallographic software package of Molecular Structure Corporation. All atoms except hydrogen atoms were refined anisotropically by full-matrix least-squares methods on F 2 using the above software package to give a final R-factor of 0.055 (R W 0.054 for all data) for 3, 0.084 (R W 0.079 for all data) for 4, and 0.066 (R W 0.082 for all data) for 9, with a data-to-parameter ratio 6.41 for 3, 6.57 for 4 and 6.24 for 9, respectively. Crystallographic data of compounds 3, 4, and 9 have been deposited at the Cambridge Crystallographic Data Centre under the reference numbers CCDC 624 324 for 3, CCDC 624 325 for 4, and CCDC 624 326 for 9.

Table 1 NMR data of compounds 4, 5 and 6
No. 4 5 6
   δH δC    δH δC    δH δC
1 2.05 (1H, q, 6.5) 39.1 1.96 (1H, m) 38.2 2.01 (1H, m) 39.0
1.47 (1H, m) 1.39 (1H, m) 1.52 (1H, m)
2 2.48 (2H, dd, 6.2, 8.9) 34.1 2.47 (2H, m) 33.7 2.50 (2H, m) 34.0
3 218.1 217.3 217.7
4 47.1 47.0 47.1
5 1.42 (1H, m) 53.9 1.52 (1H, m) 53.4 1.49 (1H, m) 53.9
6 1.53 (2H, m) 21.1 1.72 (1H, m) 20.2 1.57 (1H, m) 20.9
1.56 (1H, m) 1.45 (1H, m)
7 1.68 (1H, m) 37.8 1.45 (1H, m) 32.4 1.81 (1H, m) 37.4
1.39 (1H, m) 1.97 (1H, m) 1.48 (1H, m)
8 45.5 56.2 45.9
9 1.43 (1H, m) 45.2 1.15 (1H, m) 49.7 1.44 (1H, m) 44.0
10 38.1 38.6 37.9
11 1.52 (2H, m) 18.5 1.61 (1H, m) 20.0 1.77 (1H, m) 21.1
1.38 (1H, m) 1.57 (1H, m)
12 1.69 (1H, m) 32.9 1.80 (1H, m) 32.8 1.78 (1H, m) 39.6
1.49 (1H, m) 1.72 (1H, m) 1.60 (1H, m)
13 2.70 (1H, brs) 40.0 76.5 77.9
14 1.96 (1H, d, 12.1) 36.0 2.44 (1H, m) 44.7 2.15 (1H, d, 9.0) 44.1
1.06 (1H, m) 1.57 (1H, m) 1.18 (1H, m)
15 3.80 (1H, t, 2.4) 82.8 221.5 3.97 (1H, brs) 80.4
16 157.9 2.26 (1H, q, 6.7) 54.0 159.1
17 5.10 (1H, s) 105.1 1.11 (3H, d, 7.0) 7.3 5.19 (1H, d, 3.0) 105.8
4.99 (1H, d, 2.9) 5.21 (1H, d, 3.0)
18 1.08 (3H, s) 27.2 1.08 (3H, s) 27.1 1.09 (3H, s) 27.2
19 1.04 (3H, s) 21.0 1.03 (3H, s) 20.9 1.04 (3H, s) 21.1
20 1.10 (3H, s) 17.7 1.09 (3H, s) 17.4 1.10 (3H, s) 17.5
#

Results and Discussion

A cell suspension culture of Jungermannia subulata was grown in a liquid MSG medium under continuous light on a gyratory shaker at 25 °C. The cultured cells were green colored with small aggregated cells (Fig. [2] A). The growth curve of the cell culture and pH of the culture medium are indicated in Fig. [2] B. The cell growth entered the stationary phase on day 21. However, the pH of the medium dropped to pH 3.5 around day 15. Therefore, the cultured cells were collected by filtration during days 12 - 14 (pH range 5.0 - 5.8). The harvested cells were air-dried, and extracted with methanol and evaporated under vacuum. The methanol extract was suspended in H2O and partitioned successively against n-hexane and ethyl acetate. The n-hexane and ethyl acetate extracts were subjected to chromatographic separation to give four ent-kaurane-type diterpenoids (compounds 1 - 4) from the former, and two ent-kaurenes (compounds 5 and 6) from the latter.

Compounds 1, 2, and 3 were identified to be 3α-hydroxy-ent-16(S)-kauran-15-one [7], ent-kaurane-3,15-dione, and ent-kaur-16-ene-3,15-dione [18], respectively, by a comparison of their spectral data with literatures. Compound 2 had been isolated from the cell culture of J. subulata, and its relative structure was confirmed by X-ray analysis [6]. However, the absolute configurations of 2 and 3 were just assumed to be the ent-form on the basis of the co-occurrence with other known ent-kauranes. In this study, the absolute configuration of 2 was determined to be ent-16(S)-kaurane-3,15-dione by oxidation of compound 1 to 2 with Jones reagent. The X-ray analysis of 3 was performed to confirm the relative structure of 3 deduced from spectral data, and gave the same relative structure as previously reported (see Fig. [4], ORTEP drawing). Then, the catalytic hydrogenation of 3 over Pd-C in EtOAc yielded a dihydro-derivative, of which the spectral and physico-chemical data were coincident with those of 2. Accordingly, the absolute configuration of 3 was determined to be ent-form.

Compound 4 was obtained as crystalline needles, and its molecular formula was found to be C20H30O2 by HR-EI-MS. Its 1H- and 13C-NMR spectra were similar to those of 3, except for the presence of another methine proton bearing a hydroxy group, instead of the disappearance of one carbonyl group in 3. By detailed analysis of the HMBC spectrum, the position of the hydroxy group was determined to be C-15, and its stereochemistry was assigned as the β-orientation on the basis of NOESY correlation (H-14/H-15 in Fig. [3]). Conclusive evidence for the structure of 4 was obtained by X-ray crystallographic analysis as shown in Fig. [4]. The absolute configuration was determined to be 15β-hydroxy-ent-kaur-16-en-3-one by Jones oxidation of compound 4 to 3. Although compound 4 has been reported as a reaction product [21], this is the first report from natural origins.

Compound 5 had the molecular formula of C20H30O3 based on an HR-EI-MS peak at m/z = 318.2197. The IR absorptions (1735 and 3440 cm- 1) confirmed the presence of carbonyl and hydroxy groups. The 1H NMR spectrum exhibited a secondary methyl and three tertiary methyl protons. The 13C-NMR and HMQC spectra showed the signals of one oxygenated quaternary carbon (δ = 76.5) and two carbonyl carbons (δ = 217.3 and 221.5) as well as four methyls, seven methylenes, three methines and three quaternary carbons. The IR absorption (3440 cm-1) and an oxygenated quaternary carbon signal (C-13: δ = 76.5) suggested that 5 contained a tertiary hydroxy group. These spectral data were similar to those of 2, indicating that compound 5 belongs to the kaurane-type of diterpenoid. The detailed analysis of HMBC and NOESY spectra (Fig. [3]) revealed the structure of 5 to be 13α-hydroxykaurane-3,15-dione.

Compound 6 with the molecular formula of C20H30O3 (m/z = 318.2195 [M+]) had carbonyl and hydroxy groups on the basis of the IR spectrum (1700 and 3620 cm-1). In comparison with 5, the NMR spectra of 6 showed the presence of an exo-methylene at C-17 [δH = 5.19 (1H, d, J = 3.0 Hz) and 5.21 (1H, d, J = 3.0 Hz)] and a secondary alcohol at C-15 [δH = 3.97 (brs) and  δC = 80.4 (d)] as well as the disappearance of a secondary methyl (C-17) and a carbonyl (C-15) signal observed in 5. The structure of 6 was elucidated to be 13α,15α-dihydroxykauran-3-one by HMBC and NOESY correlations (Fig. [3]). The structure was further supported by the formation of 5 from 6 by Jones oxidation and subsequent hydrogenation. The absolute stereochemistries of 5 and 6 were assumed to be the ent-form, on the basis of the co-occurrences with other isolated compounds.

The purification of the methanol extract from the intact plant resulted in the isolation of five ent-kaurane diterpenoids (compounds 3 and 7 - 10). Compounds 7 and 8 were identified as the known ent-kaur-16-en-15-one (7) [22], and 11β-hydroxy-ent-kaur-16-en-15-one (8) [7].

Compound 9 was crystalline, had the molecular formula of C20H30O2 (m/z = 304.2240 [M]+), and its IR spectrum indicated the presences of hydroxy and carbonyl groups. The 1H NMR spectrum displayed signals for three tertiary methyl, a secondary carbinyl, and an exo-methylene proton. The 13C-NMR and HMBC spectral data indicated that 9 was 7-hydroxykaur-16-en-15-one. Although 7α-hydroxy-ent-kaur-16-en-15-one was isolated from J. truncata [23], its spectral data were not consistent with those of 9. The NOESY correlation between carbonyl proton (H-7) and methylene protons at C-14 suggested that the hydroxy group at C-7 is in a β-orientation. The stereostructure of 9 was confirmed by X-ray analysis and determined to be 7β-hydroxykaur-16-en-15-one (Fig. [3]).

Compound 10 had the molecular formula of C22H30O4 (m/z = 358.2124 [M]+). Its 1H- and 13C-NMR spectra showed the presences of an acetyl [δ = 22.0 (q) and 169.8 (s)], an exo-methylene at C-17 [δH = 5.42 (1H, d, J = 2.0 Hz) and 6.09 (1H, d, J = 2.0 Hz)], two carbonyl groups (δ = 217.0 and 206.5), and an oxygenated quarternary carbon (δ = 84.2). These spectral data were similar to those of 5 except for the presence of an acetyl and an exo-methylene group in place of a hydroxy and a secondary methyl groups, suggesting that 10 is a kaurane-type diterpene. The analysis of its HMBC and NOESY spectra established the structure of 10 as 11α-acetoxykaur-16-ene-3,15-dione. Absolute configurations of compounds 9 and 10 were deduced to be of the ent-series on the basis of the co-occurrence of the known ent-kaur-16-ene-3,15-dione (3), ent-kaur-16-en-15-one (7) [22], and 11β-hydroxy-ent-kaur-16-en-15-one (8) [7] in the intact plant.

The kaurane-type diterpenoid is one of the characteristic metabolites in Jungermannia species. Compound 1 has been isolated from J. vulcanicola [7], and compounds 2 and 3 from J. truncata [18]. Compounds 7 and 8 have already been isolated from J. infusca [22] and J. truncata [7], respectively. The productivity of kaurane compounds from cell cultures was estimated to be at almost the same level as from the intact plant. The total amount of isolated kaurane-type diterpenoids was 90 mg from 1.71 g of hexane and ethyl acetate extracts from cell culture and 61 mg from 1.78 g of hexane and ethyl acetate extracts from intact plant. ent-Kaurene is biosynthesized from geranyl geranyl diphosphate by two enzymes, coparlyl diphosphate synthase and kaurene synthase in higher plants, and/or by bifunctional kaurene synthase in the moss Physcomitrella patens [24]. Therefore, cell cultures would express ent-kaurene synthetic genes to the same extent as the intact plant. In contrast to productivity, the metabolite profile of kaurane compounds in cell cultures differed in their oxidation-reduction status from that of intact plant. Tazaki et al. [6] have also reported the isolation of compound 3, together with three ent-kaurane-type diterpenoids, ent-kaur-16-ene, 15β-hydroxy-ent-kaur-16-ene, and ent-kaur-16-en-15-one, from cell cultures of J. subulata and also described the GC-MS identification of these four kaurenes in the intact plant collected at Hokkaido (Japan). These metabolites also differed from our result in oxidation-reduction status. The oxidation or reduction of the kaurene skeleton might be catalyzed by P450 oxido-reductases, monooxygenases, and NADH/NADPH-dependent reductases. These data indicate that the expression of these oxido-reductase genes differs between cell culture and intact plant, and is affected by the culture conditions or the growth environment. This will be the subject of further studies to reveal the culture conditions affecting metabolite profiles, such as a medium composition, light, temperature, and aeration.

Zoom Image

Fig. 2 Photograph of liverwort Jungermannia subulata cell suspension culture (A), and growth curve of cell culture (B). The cell culture was incubated in 100 mL of liquid MSG medium as described in Materials and Methods.

Zoom Image

Fig. 3 HMBC and NOESY correlations of 4, 5, and 6.

Zoom Image

Fig. 4 ORTEP diagrams of 3, 4, and 9.

#

References

  • 1 Asakawa Y. Chemical constitutes of Hepaticae. In: Herz W, Grisebach H, Kirby GW, editors Progress in the chemistry of organic natural products, Vol. 42. New York; Springer 1982: 281-5.
  • 2 Matsuo A. Selected chemotaxonomic characteristics of liverwort sesquiterpenoids.  J Hattori Bot Lab. 1982;  53 295-304.
  • 3 Ohta Y, Kato K, Takeda R. Growth and secondary metabolites production in cultured cells of bryophytes. In: Chopra RN, Bhatla SC, editors Bryophyte development: physiology and biochemistry. Boca Raton; CRC Press 1990: 209-23.
  • 4 Tazaki H, Adam K P, Becker H. Five lignan derivatives from in vitro cultures of the liverwort Janesoniella autumnalis .  Phytochemistry. 1995;  40 1671-5.
  • 5 Matsuo A, Ono K, Hamasaki K, Nozaki H. Phaeophytins from a cell suspension culture of the liverwort Plagiochila ovalifolia .  Phytochemistry. 1996;  42 427-30.
  • 6 Tazaki H, Iwasaki T, Nakasuga I, Kobayashi K, Koshino H, Tanaka M. et al . ent-Kaurane-type deterpenoids produced cell culture of the liverwort Jungermannia subulata .  Phytochemistry. 1999;  52 1427-30.
  • 7 Nagashima F, Toyota M, Asakawa Y. Terpenoids from some Japanese liverworts.  Phytochemistry. 1990;  29 2169-74.
  • 8 Matsuo A, Nakayama M, Hayashi S, Seki T, Amakawa T. A comparative study of the diterpenoids from several species of the genus Jungermannia . In: Claude S, editor Congress International de Bryologie, Bordeaux Nov. 21 - 23, Bryophytorum Bibliotheca, Vol. 13. Stuttgart; Schweizerbart Publishers 1977: 322-8.
  • 9 Asakawa Y. Chemosystematics of the Hepaticae.  Phytochemistry. 2004;  65 623-69.
  • 10 Nagashima F, Kondoh M, Kawase M, Simizu S, Osada H, Fujii M. et al . Apoptosis-inducing properties of ent-kaurene-type diterpenoids from the liverwort Jungermannia truncata .  Planta Med. 2003;  69 377-9.
  • 11 Suzuki I, Kondoh M, Harada M, Koizumi N, Fujii M, Nagashima F. et al . An ent-kaurene diterpene enhances apoptosis induced by tumor necrosis factor in human leukemia cells.  Planta Med. 2004;  70 723-7.
  • 12 Kondoh M, Nagashima F, Suzuki I, Harada M, Fujii M, Asakawa Y. et al . Induction of apoptosis by new ent-kaurene-type diterpenoids isolated from the New Zealand liverwort Jungermannia species.  Planta Med. 2005;  71 1005-9.
  • 13 Nagashima F, Kasai W, Kondoh M, Fujii M, Watanabe Y, Braggins J E. et al . New ent-kaurene-type diterpenoids possessing cytotoxicity from the New Zealand liverwort Jungermannia species.  Chem Pharm Bull. 2003;  51 1189-92.
  • 14 Yeh S H, Chang F R, Wu Y C, Yang Y L, Zhuo S K, Hwang T L. An anti-inflammatory ent-kaurane from the stems of Annona squamosa that inhibits various human neutrophil functions.  Planta Med. 2005;  71 904-9.
  • 15 Yang Y L, Chang F R, Wu C C, Wang W Y, Wu Y C. New ent-kaurane diterpenoids with anti-platelet aggregation activity from Annona squamosa .  J Nat Prod. 2002;  65 1462-7.
  • 16 Yang Y L, Chang F R, Hwang T L, Chang W T, Wu Y C. Inhibitory effects of ent-kauranes from the stems of Annona squamosa on superoxide anion generation by human neutrophils.  Planta Med. 2004;  70 256-8.
  • 17 Wu Y C, Hung Y C, Chang F R, Cosentino M, Wang H K, Lee K H. Identification of ent-16β, 17-dihydroxykauran-19-oic acid as an anti-HIV principle and isolation of the new diterpenoids annosquamosins A and B from Annona squamosa .  J Nat Prod. 1996;  59 635-7.
  • 18 Liu H J, Tseng S H, Wu J D, Wu C L. Kaurane-type diterpenoids from liverworts.  J Chin Chem Soc (Taipei). 1997;  44 385-9.
  • 19 Nagashima F, Suzuki M, Asakawa Y. Seco-cuparane-type sesquiterpenoid from the Japanese liverwort Jungermannia infusca .  Phytochemistry. 2001;  56 807-10.
  • 20 Murashige T, Skoog F. A revised media for rapid growth and bioassay with tobacco cultures.  Physiol Plant. 1962;  15 473-97.
  • 21 Fraga B M, Guillermo R, Hernandez M G. The microbiological transformation of two 15β-hydroxy-ent-kaurene diterpenes by Gibberella fujikuroi .  J Nat Prod. 2004;  67 64-9.
  • 22 Matsuo A, Kodama J, Nakayama M, Hayashi S. ent-Kaurene diterpenoids from the liverwort Jungermannia infusca .  Phytochemistry. 1977;  16 489-90.
  • 23 Buchana M S, Connolly J D, Kadir A A, Rycroft D S. Sesquiterpenoids and diterpenoids from the liverwort Jungermannia truncata .  Phytochemistry. 1996;  42 1641-6.
  • 24 Hayashi K, Kawaide H, Notomi M, Sakigi Y, Matsuo A, Nozaki H. Identification and functional analysis of bifunctional ent-kaurene synthase from the moss Physcomitrella patens .  FEBS Lett.. 2006;  580 6175-81.

Prof. Dr. Hiroshi Nozaki

Department of Biochemistry

Okayama University of Science

1-1 Ridai-cho

Okayama City 700-0005

Japan

Phone: +81-86-256-9460

Fax: +81-86-256-9559

Email: nozaki@dbc.ous.ac.jp

#

References

  • 1 Asakawa Y. Chemical constitutes of Hepaticae. In: Herz W, Grisebach H, Kirby GW, editors Progress in the chemistry of organic natural products, Vol. 42. New York; Springer 1982: 281-5.
  • 2 Matsuo A. Selected chemotaxonomic characteristics of liverwort sesquiterpenoids.  J Hattori Bot Lab. 1982;  53 295-304.
  • 3 Ohta Y, Kato K, Takeda R. Growth and secondary metabolites production in cultured cells of bryophytes. In: Chopra RN, Bhatla SC, editors Bryophyte development: physiology and biochemistry. Boca Raton; CRC Press 1990: 209-23.
  • 4 Tazaki H, Adam K P, Becker H. Five lignan derivatives from in vitro cultures of the liverwort Janesoniella autumnalis .  Phytochemistry. 1995;  40 1671-5.
  • 5 Matsuo A, Ono K, Hamasaki K, Nozaki H. Phaeophytins from a cell suspension culture of the liverwort Plagiochila ovalifolia .  Phytochemistry. 1996;  42 427-30.
  • 6 Tazaki H, Iwasaki T, Nakasuga I, Kobayashi K, Koshino H, Tanaka M. et al . ent-Kaurane-type deterpenoids produced cell culture of the liverwort Jungermannia subulata .  Phytochemistry. 1999;  52 1427-30.
  • 7 Nagashima F, Toyota M, Asakawa Y. Terpenoids from some Japanese liverworts.  Phytochemistry. 1990;  29 2169-74.
  • 8 Matsuo A, Nakayama M, Hayashi S, Seki T, Amakawa T. A comparative study of the diterpenoids from several species of the genus Jungermannia . In: Claude S, editor Congress International de Bryologie, Bordeaux Nov. 21 - 23, Bryophytorum Bibliotheca, Vol. 13. Stuttgart; Schweizerbart Publishers 1977: 322-8.
  • 9 Asakawa Y. Chemosystematics of the Hepaticae.  Phytochemistry. 2004;  65 623-69.
  • 10 Nagashima F, Kondoh M, Kawase M, Simizu S, Osada H, Fujii M. et al . Apoptosis-inducing properties of ent-kaurene-type diterpenoids from the liverwort Jungermannia truncata .  Planta Med. 2003;  69 377-9.
  • 11 Suzuki I, Kondoh M, Harada M, Koizumi N, Fujii M, Nagashima F. et al . An ent-kaurene diterpene enhances apoptosis induced by tumor necrosis factor in human leukemia cells.  Planta Med. 2004;  70 723-7.
  • 12 Kondoh M, Nagashima F, Suzuki I, Harada M, Fujii M, Asakawa Y. et al . Induction of apoptosis by new ent-kaurene-type diterpenoids isolated from the New Zealand liverwort Jungermannia species.  Planta Med. 2005;  71 1005-9.
  • 13 Nagashima F, Kasai W, Kondoh M, Fujii M, Watanabe Y, Braggins J E. et al . New ent-kaurene-type diterpenoids possessing cytotoxicity from the New Zealand liverwort Jungermannia species.  Chem Pharm Bull. 2003;  51 1189-92.
  • 14 Yeh S H, Chang F R, Wu Y C, Yang Y L, Zhuo S K, Hwang T L. An anti-inflammatory ent-kaurane from the stems of Annona squamosa that inhibits various human neutrophil functions.  Planta Med. 2005;  71 904-9.
  • 15 Yang Y L, Chang F R, Wu C C, Wang W Y, Wu Y C. New ent-kaurane diterpenoids with anti-platelet aggregation activity from Annona squamosa .  J Nat Prod. 2002;  65 1462-7.
  • 16 Yang Y L, Chang F R, Hwang T L, Chang W T, Wu Y C. Inhibitory effects of ent-kauranes from the stems of Annona squamosa on superoxide anion generation by human neutrophils.  Planta Med. 2004;  70 256-8.
  • 17 Wu Y C, Hung Y C, Chang F R, Cosentino M, Wang H K, Lee K H. Identification of ent-16β, 17-dihydroxykauran-19-oic acid as an anti-HIV principle and isolation of the new diterpenoids annosquamosins A and B from Annona squamosa .  J Nat Prod. 1996;  59 635-7.
  • 18 Liu H J, Tseng S H, Wu J D, Wu C L. Kaurane-type diterpenoids from liverworts.  J Chin Chem Soc (Taipei). 1997;  44 385-9.
  • 19 Nagashima F, Suzuki M, Asakawa Y. Seco-cuparane-type sesquiterpenoid from the Japanese liverwort Jungermannia infusca .  Phytochemistry. 2001;  56 807-10.
  • 20 Murashige T, Skoog F. A revised media for rapid growth and bioassay with tobacco cultures.  Physiol Plant. 1962;  15 473-97.
  • 21 Fraga B M, Guillermo R, Hernandez M G. The microbiological transformation of two 15β-hydroxy-ent-kaurene diterpenes by Gibberella fujikuroi .  J Nat Prod. 2004;  67 64-9.
  • 22 Matsuo A, Kodama J, Nakayama M, Hayashi S. ent-Kaurene diterpenoids from the liverwort Jungermannia infusca .  Phytochemistry. 1977;  16 489-90.
  • 23 Buchana M S, Connolly J D, Kadir A A, Rycroft D S. Sesquiterpenoids and diterpenoids from the liverwort Jungermannia truncata .  Phytochemistry. 1996;  42 1641-6.
  • 24 Hayashi K, Kawaide H, Notomi M, Sakigi Y, Matsuo A, Nozaki H. Identification and functional analysis of bifunctional ent-kaurene synthase from the moss Physcomitrella patens .  FEBS Lett.. 2006;  580 6175-81.

Prof. Dr. Hiroshi Nozaki

Department of Biochemistry

Okayama University of Science

1-1 Ridai-cho

Okayama City 700-0005

Japan

Phone: +81-86-256-9460

Fax: +81-86-256-9559

Email: nozaki@dbc.ous.ac.jp

Zoom Image

Fig. 1 Chemical structures of kaurane-type diterpenoids (1 - 10) from the cell suspension culture and intact plant of the liverwort Jungermannia subulata.

Zoom Image

Fig. 2 Photograph of liverwort Jungermannia subulata cell suspension culture (A), and growth curve of cell culture (B). The cell culture was incubated in 100 mL of liquid MSG medium as described in Materials and Methods.

Zoom Image

Fig. 3 HMBC and NOESY correlations of 4, 5, and 6.

Zoom Image

Fig. 4 ORTEP diagrams of 3, 4, and 9.